We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DNA2 Doric Nimrod Air Two Limited

1.00 (0.87%)
01 Dec 2023 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Doric Nimrod Air Two Limited LSE:DNA2 London Ordinary Share GG00B3Z62522 ORD PREF SHS NPV
  Price Change % Change Share Price Shares Traded Last Trade
  1.00 0.87% 116.00 123,818 14:54:19
Bid Price Offer Price High Price Low Price Open Price
115.00 117.00 116.00 115.00 115.00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Equip Rental & Leasing, Nec 132.78M 63.44M 0.3673 3.16 200.39M
Last Trade Time Trade Type Trade Size Trade Price Currency
15:44:52 O 62,500 115.00 GBX

Doric Nimrod Air Two (DNA2) Latest News

Doric Nimrod Air Two (DNA2) Discussions and Chat

Doric Nimrod Air Two Forums and Chat

Date Time Title Posts
29/11/202317:00Profit from airline leasing52

Add a New Thread

Doric Nimrod Air Two (DNA2) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type

Doric Nimrod Air Two (DNA2) Top Chat Posts

Top Posts
Posted at 01/12/2023 08:20 by Doric Nimrod Air Two Daily Update
Doric Nimrod Air Two Limited is listed in the Equip Rental & Leasing, Nec sector of the London Stock Exchange with ticker DNA2. The last closing price for Doric Nimrod Air Two was 115p.
Doric Nimrod Air Two currently has 172,750,000 shares in issue. The market capitalisation of Doric Nimrod Air Two is £200,390,000.
Doric Nimrod Air Two has a price to earnings ratio (PE ratio) of 3.16.
This morning DNA2 shares opened at 115p
Posted at 28/11/2023 17:06 by grahamg8
The share price will presumably level off at a cruising altitude of 120p. A bit more climbing still needed.
Posted at 16/2/2023 10:00 by b2baby
Avation announced this morning that they have sold a Boing 737-800. This can only be good news for the resurrection of a proper second hand market in commercial aircraft and therefore only positive for DNA2. Most travel stocks showing major uptake for 2023 indicating that although cost of living is biting on many fronts, many are still putting money aside for holidays. Again, only positive for DNA2.
Posted at 17/10/2022 21:04 by rambutan2
Weiss out:

And Elliot in:

Trades made at 91.5p:
Posted at 13/7/2021 16:08 by grahamg8
Last week Insight Investment Management offloaded 9.72% of DNA and 2.69% DNA2 and didn't make a dent in the share price. Someone keen to buy, awaiting RNS to reveal all. Meanwhile by my calculation a quarterly update is due tomorrow.
Posted at 13/12/2014 01:19 by extrader
Hi Valhamos,

Thanks for the feedback - and the lead to DPA.

My partner is American and we spend some time Stateside every year (in fact I'm writing from California at the moment). So the USD aspect is not necessarily a negative !

In 'further fact', by coincidence , we must have flown here (to LAX) on one of the two Dreamliners leased from DPA by Norwegian Air......

On a customer feedback note, the plane was indeed quieter than my previous hops,the air quality the best I've ever had, so much less jet-lag; the seat configuration good, the food and inflight entertainment good. The larger shutterless windows were great for viewing, but not so good at keeping out the glare of direct sunlight (they're not physical shutters, just an electronically adjustable photo-sensitive pane).

The ticket price was also v competitive, certainly better value than our usual United/Virgin/BA....

Coming back on topic, I'd imagine the residual value of a twin engine, 'standard' body long-range 787 would be higher than the A380, with its 4 engines, high passenger load requirement and special airbridges needed.

So, more DMOR, but thanks again for the so far promising lead.

Posted at 12/12/2014 09:55 by wirralowl
I'd be very cautious atm extrader, with news just out yesterday from Airbus, about potentially ceasing production of the A380, or upgrading the current version with more efficient engines. Made me wonder where this would leave DNA at the end of their leases, if either of those cases pan out:

Particularly worrying was the quote from Emirates boss, Tim Clark, who said 'the stance would not help the future second-hand value of A380 aircraft.'

On the back of this news, I regretfully bailed on my holdings in DNA and DNA2, and intend to sit on the sidelines and see how this all unfolds now.
Posted at 12/12/2014 04:32 by extrader
Hi all,

Looking at some medium term income for a couple of portfolios....and DNA2, running to 2023 and DNA3 running to 2025 seem to fit the bill as far as yield goes (around 8% at the moment).

Question is : what happens at the end of the lease ie when debt has been paid off and we own the aircraft. What are they likely to be worth then ?

Will the residual value leave shareholders with a capital gain, their capital back, or a capital loss ?

Interesting article (a bit dated) suggesting that the outlook isn't too rosy....

With 36 A380 aircraft in the fleet as of late September and a further 104 now on order, the aviation community is trying to calculate what will happen to Emirates’ superjumbo fleet when the time comes to retire the type, at around halfway through its lifetime. Some analysts believe that, given a lifespan of 25 years, a proxy for the useful life of a modern widebody aircraft, the A380 will face problems in the secondary market when major leases come to an end after the standard 12-year term......


Some punchy input from other industry analysts and a fairly subdued reply from Doric, I thought.

Maybe a suitable investment on a 5 year horizon, but arguably not one to be holding when the music/lease stops ?

Posted at 22/6/2014 08:41 by grahamg8
Well it's time to find some cash for my pension payout in July so I had a look at the Nimrods. DNA share price seems to be very stable. DNA2 most volatile and below recent highs but still above the March lows. So it could rise or fall. DNA3 below recent highs and so my strategy seems to be buy DNA3 into my ISA and sell an equivalent amount in my SIPP. ie lower chance of falls, some chance of a rise, and of course I keep hold of those juicy dividends.
Posted at 22/1/2014 16:42 by speedsgh
DNA - last published NAV (30/9/13) 101.69p - current mid price 116.50p - premium to NAV +14.5% - current yield 7.7%
DNA2 - last published NAV (30/9/13) 193.09p - current mid price 230p - premium to NAV +19% - current yield 7.8%
DNA3 - last published NAV (30/9/13) 92.74p - current mid price 110.50p - premium to NAV +19% - current yield 7.5% (once full payments of 2.0625p/qtr commence)
Posted at 19/1/2014 17:31 by grahamg8
onehand you can't look at DNA2 in isolation. Check out my posts on DNA #4 and DNA3 #2. As I suggeted DNA2 was overpriced and it has fallen, DNA seems to be the benchmark and down slightly whereas DNA3 has risen. Appx movements -5.5%, -1.5%, +0.9%. The relative prices have simply been sorting themselves out and now more nearly represent equal value than before IMO. You wont be surprised to learn that based on the sentiment expressed back in November I bought 1 and 3 and steered clear of 2. Got it right for once.
Doric Nimrod Air Two share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |